IPO

GlobalTech Corporation's move to the OTCQB market is more than a formality; it's a calculated step to boost transparency and fuel its AI-driven Nasdaq ambition.

A new auto marketplace is betting it can disrupt giants like CarGurus by eliminating upfront dealer fees and capturing buyers priced out of the new car market.

A new RNA drug shows promise by reducing harmful belly fat while preserving muscle, but modest overall weight loss in early trials spooks investors.

China Mobile's new Global Intelligence Center in Hong Kong aims to supercharge the city's AI sector and serve as a key node in Beijing's global ambitions.

A new partnership aims to put gold on the blockchain, highlighting a trillion-dollar trend where real-world assets are reshaping the future of finance.

Lumexa Imaging posted strong 2025 revenue and cut its debt, yet a surprise net loss and EPS miss sent its stock tumbling. What's next for the imaging giant?

Autonomous driving firm Pony.ai announces a first-ever quarterly profit and a bold plan to deploy 3,000 robotaxis globally by the end of 2026.

The successful launch of rosacea treatment Emrosi™ generated $14.7M, driving Journey Medical's revenue to $61.9M and signaling a major strategic win.

In a critical exercise, Firefly Aerospace and Lockheed Martin proved satellites can be readied in hours, a key step in the U.S. plan for space defense.

ILCO's 2025 net profit plummets, hit by its ICL holding, yet a successful IPO and dividend payout reveal a company navigating headwinds with strategic shifts.

The MEMS specialist saw revenue dip on a sharp medical decline, but booming aerospace sales, a higher margin, and a new dividend signal a strategic pivot.

A federal judge's ruling allows a lawsuit to proceed over an alleged $2.2B valuation gap, placing the secretive world of corporate appraisal under a microscope.

A major gold deal in Kyrgyzstan faces legal threats as international investors allege a lack of transparency and disregard for their rights in a pivotal sale.

As AI reshapes the $10 trillion wellness industry, one franchise doubles down on an old-school approach: human empathy. But can it truly compete?

Celebrating its public listing, Our Bond, Inc. highlights its mission to redefine safety with a preventative AI platform already used by global giants.

The tea giant's revenue soars 36% as it surpasses 11,000 stores, but can its franchise-led model withstand intense competition and growing pains?

A new FDA-cleared device uses water vapor to ablate prostate tissue, showing high efficacy in trials while minimizing life-altering side effects.

MJP Wealth Advisors President Brian Vendig joins the elite Barron’s 2026 list, a nod to the firm's rapid growth and sophisticated client strategies.

Amid a record-breaking boom in convertible securities, Wellesley Asset Management launches its MCVT ETF, offering investors actively managed access to this hybrid asset.

A new regulated platform from STS Digital, backed by Kraken, unlocks sophisticated investment strategies across 400+ digital assets for institutions.